Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nasdaq Inc (NDAQ) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Nasdaq IncTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Nasdaq Inc vs Vir Biotechnology Inc. Common Stock — how do they compare? Nasdaq Inc trades at $91.86 (market cap $52.25B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Nasdaq Inc is far larger — about 29× Vir Biotechnology Inc. Common Stock's market cap, and Nasdaq Inc pays a 1.24% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nasdaq Inc for 126 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

NDAQVIR
Market Cap
$52.25B$1.80B
Volume
2,420,8341,782,836
Sector
FinancialsHealth
52-Week High
$100.98$11.78
52-Week Low
$76.85$5.12
Typical Hold Time
126 Days0 Days
Enterprise Value
$58.71B$1.36B
Dividend Yield
1.24%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nasdaq Inc

Nasdaq (NDAQ) trades at $91.96, down 2.47% on the day, with a bullish technical outlook supported by moving averages. The company shows strong fundamentals with 2025 revenue of $8.26B and net income of $1.79B, achieving a 21.64% profit margin. Recent earnings beats and analyst consensus of $110.43 price target reflect confidence in growth driven by financial technology and AI initiatives.

NDAQ presents a compelling investment case with solid profitability and strategic positioning in market infrastructure. Key risks include market volatility sensitivity and debt levels, but strong cash flow and institutional support provide stability. The stock offers upside potential aligned with analyst targets, supported by recurring revenue growth and technology adoption.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NDAQ
64% Buy36% Sell
Avg holding period · 126 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

About Nasdaq Inc

Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.

Read more on NDAQ →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →